Search Results

67 Results for "syntimmune".

Sort By

Deals

Alexion to Obtain Syntimmune for $400M up Front

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune have just today announced that Alexion will be acquiring Syntimmune, a company working to produce antibody therapeutics that focus on the neonatal Fc receptor (FcRn).

September 26, 2018
·
3 min read
·
Elizabeth Glasure
Genetown

Syntimmune to Present at Jefferies 2018 Global Healthcare Conference

Syntimmune, Inc. announced that President and Chief Executive Officer Jean-Paul Kress, M.D., will present at the Jefferies 2018 Global Healthcare Conference.

June 4, 2018
·
2 min read
Drug Development

Syntimmune Announces FDA Orphan Drug Designation for SYNT001 in Treatment of Pemphigus

Syntimmune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to SYNT001.

September 12, 2018
·
4 min read
Business

NYC Startup Syntimmune Names Former Biogen Exec as New CEO

Syntimmune has appointed Jean-Paul Kress as president and CEO.

January 3, 2018
·
2 min read
·
Mark Terry
Business

Syntimmune Appoints Andrew Cheng, M.D., Ph.D., to Board of Directors, Bolstering Clinical Development Expertise

Syntimmune, Inc. is a clinical-stage biotechnology company developing antibody therapeutics targeting FcRn

April 25, 2018
·
2 min read
Press Releases

Presse release: Jean-Paul Kress to join Sanofi’s Board of Directors

December 20, 2024
·
3 min read
Business

Alexion to Acquire Syntimmune

Brings in clinical-stage anti-FcRn antibody SYNT001 with potential to address a number of rare IgG-mediated diseases

September 26, 2018
·
10 min read
Deals

Alexion Completes Acquisition of Syntimmune

Acquisition adds clinical-stage anti-FcRn antibody SYNT001 to company’s growing pipeline

November 2, 2018
·
7 min read
Business

Syntimmune Strengthens Leadership Team with Appointment of Chief Medical Officer

Dr. Mario Saltarelli brings 25 years of experience from Vertex, Annexon, Shire, AbbVie and Pfizer

July 9, 2018
·
4 min read
Drug Development

Syntimmune Announces Breakthrough Results Of FcRn Inhibition Published In PNAS

March 21, 2017
·
5 min read